(Photo Courtesy: www.eship.ox.ac.uk)
However, their unwavering self-belief, hard work and patience has started paying off.
GNG was founded in 2011, with a focus in the areas of diagnostic and therapeutic proteins development, cellular and molecular assay development and contract research services.
The company has expertise in protein and antibody engineering, expression and production.
"We have developed a platform whereby we can deliver antibody quickly without the need of immunization," says Ms Supriya, a Biologist.
Its research focus is in developing antibody for research, diagnostics and therapeutics.